Breaking News Instant updates and real-time market news.

NKTR

Nektar

$85.79

(0.00%)

09:37
05/17/18
05/17
09:37
05/17/18
09:37

Technical Take: Nektar falls sharply, levels to watch

The stock was last down over 5% to $81.43, off the earlier low set at $78.11 which is now support. At current price next resistance is at $82.59.

  • 21

    May

  • 12

    Jun

NKTR Nektar
$85.79

(0.00%)

05/17/18
JPMS
05/17/18
NO CHANGE
JPMS
Nektar may sell off modestly on ASCO abstract, says JPMorgan
JPMorgan analyst Jessica Fye says that consistent with her expectation heading into last night's abstracts, Nektar Therapeutics' NKTR-214 update was not definitive as it relates to the ultimate profile for the product. Management emphasized in advance that follow up would be limited for the new patients in the abstract, and this was "abundantly evident" with 22 of the 30 Phase II patients having had only one scan, Fye tells investors in a research note. Overall, the analyst sees "bright spots" in the abstract from signs of durable responses, tolerability, and an "intriguing" signal in bladder cancer. She notes, however, that some investors will pick at the decreased overall response rates in the new patients in melanoma, renal cell carcinoma and lung. While the limited follow up in the abstract was well-telegraphed, Nektar shares trading modestly lower today would not be surprising, Fye writes. The analyst keeps an Overweight rating on the stock.
05/16/18
PIPR
05/16/18
NO CHANGE
Target $125
PIPR
Overweight
Nektar 214+nivo response for melanoma not conclusive, says Piper Jaffray
Piper Jaffray analyst Tyler Van Buren keeps his Overweight rating and $125 price target on Nektar (NKTR) after the release of PIVOT ASCO abstract of NKTR 214+nivo (BMY). The analyst says that while the 1L melanoma response rate may be "slightly lower than some had hoped for", the 1L RCC response rate were "nicely above" what has been seen with ipi+nivo treatment. Van Buren adds that while small in numbers, "3/4 responses in 1L bladder and 1/3 responses in triple negative breast cancer are encouraging." The analyst believes that the stock may be down in the morning, but investors should not come to "rash conclusions", as the ASCO presentation with more patients and detail is likely to be positive.
05/14/18
HCWC
05/14/18
NO CHANGE
Target $125
HCWC
Buy
Nektar pullbacks 'could get compelling,' says H.C. Wainwright
H.C. Wainwright analyst Debjit Chattopadhyay said ASCO abstracts featuring data from Nektar's ongoing PIVOT-02 study have potentially reset expectations, but he also noted that the actual podium presentation is likely to include an updated cut of data from up to late May. The analyst, who thinks pullbacks in Nektar Therapeutics shares "could get compelling," maintains a Buy rating and $125 price target on the stock.
05/11/18
PIPR
05/11/18
NO CHANGE
Target $125
PIPR
Overweight
Piper expects positive oral presentation from Nektar in early June
Piper Jaffray analyst Tyler Van Buren believes next Wednesday's ASCO abstract for Nektar's Phase I/II Pivot study of NKTR-214 in combination with nivolumab will be one of the most highly anticipated abstracts of the conference. The analyst notes, however, that the abstract will be from a February data cut while the oral presentation in early June will be from a data cut later this month. As such, the oral presentation will contain "significantly more mature data and should ultimately be relied on to make conclusions about the anti-tumor activity," Van Buren tells investors in a research note. He believes the oral presentation will be positive and keeps an Overweight rating on Nektar Therapeutics with a $125 price target following the company's Q1 results.

TODAY'S FREE FLY STORIES

SPWR

SunPower

$7.55

0.97 (14.74%)

07:41
09/19/18
09/19
07:41
09/19/18
07:41
Upgrade
SunPower rating change  »

SunPower upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VCRA

Vocera

$33.51

0.01 (0.03%)

07:41
09/19/18
09/19
07:41
09/19/18
07:41
Initiation
Vocera initiated  »

Jefferies starts Vocera…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

JNPR

Juniper

$28.60

0.6 (2.14%)

07:37
09/19/18
09/19
07:37
09/19/18
07:37
Upgrade
Juniper rating change  »

Nomura upgrades Juniper…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 26

    Sep

  • 27

    Sep

  • 03

    Oct

  • 04

    Oct

  • 05

    Oct

  • 11

    Oct

  • 16

    Oct

BWA

BorgWarner

$42.99

-1.17 (-2.65%)

07:37
09/19/18
09/19
07:37
09/19/18
07:37
Recommendations
BorgWarner analyst commentary  »

BorgWarner price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

NOK

Nokia

$5.62

0.125 (2.27%)

07:36
09/19/18
09/19
07:36
09/19/18
07:36
Downgrade
Nokia rating change  »

Nokia downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MKTX

MarketAxess

$181.58

1.8 (1.00%)

07:35
09/19/18
09/19
07:35
09/19/18
07:35
Conference/Events
MarketAxess management to meet with Compass Point »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

PBR

Petrobras

$11.23

0.305 (2.79%)

, TLRY

Tilray

$154.99

34.79 (28.94%)

07:35
09/19/18
09/19
07:35
09/19/18
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

PBR

Petrobras

$11.23

0.305 (2.79%)

TLRY

Tilray

$154.99

34.79 (28.94%)

STZ

Constellation Brands

$213.44

1.24 (0.58%)

FIT

Fitbit

$5.80

0.35 (6.42%)

DLTR

Dollar Tree

$85.20

-0.3 (-0.35%)

EDU

New Oriental Education

$67.58

-1.22 (-1.77%)

UNP

Union Pacific

$163.70

6.97 (4.45%)

ETE

Energy Transfer Equity

$17.39

0.08 (0.46%)

SGMS

Scientific Games

$26.40

1.525 (6.13%)

YELP

Yelp

$49.98

3.695 (7.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

  • 04

    Oct

  • 10

    Oct

  • 13

    Oct

  • 28

    Oct

  • 06

    Nov

CCXI

ChemoCentryx

$11.51

1.01 (9.62%)

07:35
09/19/18
09/19
07:35
09/19/18
07:35
Recommendations
ChemoCentryx analyst commentary  »

ChemoCentryx weakness a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

07:35
09/19/18
09/19
07:35
09/19/18
07:35
General news
U.S. MBA mortgage market index rose 1.6% »

U.S. MBA mortgage market…

ATHN

Athenahealth

$135.25

-8.005 (-5.59%)

07:34
09/19/18
09/19
07:34
09/19/18
07:34
Recommendations
Athenahealth analyst commentary  »

Athenahealth price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKE

Nike

$85.29

2.04 (2.45%)

07:34
09/19/18
09/19
07:34
09/19/18
07:34
Recommendations
Nike analyst commentary  »

Morgan Stanley says Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

  • 20

    Sep

  • 25

    Sep

AIHS

Senmiao Technology

$5.10

-0.12 (-2.30%)

07:32
09/19/18
09/19
07:32
09/19/18
07:32
Hot Stocks
Senmiao Technology names Xiaoyuan Zhang as CFO, succeeding Rong Zhu »

Senmiao Technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOK

Nokia

$5.62

0.125 (2.27%)

07:32
09/19/18
09/19
07:32
09/19/18
07:32
Upgrade
Nokia rating change  »

Nokia upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEPT

Neptune Technologies

$4.26

0.045 (1.07%)

07:31
09/19/18
09/19
07:31
09/19/18
07:31
Hot Stocks
Neptune Technologies approves name change to Neptune Wellness Solutions »

Neptune Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBY

Best Buy

$77.70

0.67 (0.87%)

, SEAS

SeaWorld

$31.20

0.02 (0.06%)

07:30
09/19/18
09/19
07:30
09/19/18
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

BBY

Best Buy

$77.70

0.67 (0.87%)

SEAS

SeaWorld

$31.20

0.02 (0.06%)

BGS

B&G Foods

$30.30

-1.25 (-3.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 06

    Nov

QCOM

Qualcomm

$74.73

1.48 (2.02%)

07:30
09/19/18
09/19
07:30
09/19/18
07:30
Recommendations
Qualcomm analyst commentary  »

Qualcomm price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:30
09/19/18
09/19
07:30
09/19/18
07:30
General news
Treasury Market Outlook: yields cheapened overnight »

Treasury Market Outlook:…

JMP

JMP Group

$5.31

0.015 (0.28%)

07:29
09/19/18
09/19
07:29
09/19/18
07:29
Conference/Events
JMP Group management to meet with Barrington »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

EGN

Energen

$79.34

1.2 (1.54%)

07:29
09/19/18
09/19
07:29
09/19/18
07:29
Downgrade
Energen rating change  »

Energen downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDX

FedEx

$241.58

-14.22 (-5.56%)

07:27
09/19/18
09/19
07:27
09/19/18
07:27
Conference/Events
FedEx management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 21

    Sep

  • 24

    Sep

  • 03

    Oct

  • 04

    Oct

SBRA

Sabra Health Care

$23.32

-0.04 (-0.17%)

07:26
09/19/18
09/19
07:26
09/19/18
07:26
Initiation
Sabra Health Care initiated  »

Sabra Health Care…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IOTS

Adesto Technologies

$6.05

-0.05 (-0.82%)

07:26
09/19/18
09/19
07:26
09/19/18
07:26
Recommendations
Adesto Technologies analyst commentary  »

Adesto Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 09

    Oct

NBIX

Neurocrine

$120.32

3.03 (2.58%)

07:25
09/19/18
09/19
07:25
09/19/18
07:25
Recommendations
Neurocrine analyst commentary  »

Cantor more confident in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:25
09/19/18
09/19
07:25
09/19/18
07:25
General news
FX Update: The dollar traded mostly softer »

FX Update: The dollar…

PGR

Progressive

$69.68

1.15 (1.68%)

07:24
09/19/18
09/19
07:24
09/19/18
07:24
Recommendations
Progressive analyst commentary  »

Progressive price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.